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AbstrACt
Introduction There are growing concerns about 
the increase in rates of commonly used childbirth 
interventions. When indicated, childbirth interventions 
are crucial for preventing maternal and perinatal 
morbidity and mortality, but their routine use in healthy 
women and children leads to avoidable maternal and 
neonatal harm. Establishing ideal rates of interventions 
can be challenging. This study aims to describe the 
range of variations in the use of commonly used 
childbirth interventions in high-income countries 
around the world, and in outcomes in nulliparous and 
multiparous women.
Methods and analysis This multinational cross-
sectional study will use data from births in 2013 with 
national population data or representative samples of the 
population of pregnant women in high-income countries. 
Data from women who gave birth to a single child from 
37 weeks gestation onwards will be included and the 
results will be presented for nulliparous and multiparous 
women separately. Anonymised individual level data will 
be analysed. Primary outcomes are rates of commonly 
used childbirth interventions, including induction and/or 
augmentation of labour, intrapartum antibiotics, epidural 
and pharmacological pain relief, episiotomy in vaginal 
births, instrument-assisted birth (vacuum or forceps), 
caesarean section and use of oxytocin postpartum. 
Secondary outcomes are maternal and perinatal mortality, 
Apgar score below 7 at 5 min, postpartum haemorrhage 
and obstetric anal sphincter injury. Univariable and 
multivariable logistic regression analyses will be 
conducted to investigate variations among countries, 
adjusted for maternal age, body mass index, gestational 
weight gain, ethnic background, socioeconomic status 
and infant birth weight. The overall mean rates will be 
considered as a reference category, weighted for the size 
of the study population per country.
Ethics and dissemination The Medical Ethics Review 
Committee of VU University Medical Center Amsterdam 
confirmed that an official approval of this study was not 
required. Results will be disseminated at national and 
international conferences and published in peer-reviewed 
journals.
bACkground
There are growing concerns about the 
increase in rates of commonly used child-
birth interventions. When indicated, child-
birth interventions are crucial for preventing 
maternal and perinatal morbidity and 
mortality, and medical technology has led to 
improved maternal and perinatal outcomes in 
the last decades1 However, the routine use of 
these interventions in healthy low-risk women 
and children leads to avoidable maternal 
and neonatal harm and rising healthcare 
costs.2–7 The rate of childbirth interventions 
varies both geographically and over different 
time periods,3 8–10 even within groups of 
women with identical risk profiles, and has 
risen for some interventions and declined 
for others.8 10–13 In low-income countries, 
a very low caesarean section (CS) rate has 
been reported with a high risk of maternal 
mortality. Due to inadequate access to high-
quality intrapartum care in these countries, 
most stillbirths in these countries are prevent-
able.14 CS and labour induction rates have 
shown a steady increase since the 1970s in 
high-income countries8 10 12 15 16 However, CS 
rates higher than 10% are not associated with 
lower maternal and perinatal mortality.17 18 In 
contrast to the increase of CS rates, the episi-
otomy rate has declined in many countries 
strengths and limitations of this study
 ► The use of crude data at the level of individual 
women.
 ► The use of strict definitions of variables.
 ► Multivariable analyses to make more valid 
comparisons between countries.
 ► Missing variables in multivariable analyses.
 ► Different quality standards for data across countries.
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since the 1980s.8 19 20 WHO has stated that episiotomy 
rates should be no higher than 10%.21 
While establishing ideal rates of childbirth interven-
tions is a challenge,22 23 high rates of interventions should 
be avoided, especially among low-risk women, because of 
the risk of adverse effects. CSs are associated with adverse 
perinatal outcomes,24 postoperative complications25 26 
and avoidable maternal and fetal risks in subsequent preg-
nancies.27 Therefore, CSs should only be performed for 
strict medical and obstetric indications. Other inter-
ventions, such as induction of labour, augmentation of 
labour, epidural anaesthesia, instrument-assisted birth 
and episiotomy, if performed without medical indication, 
can lead to avoidable adverse maternal and perinatal 
outcomes.28–31
Several studies have reported international variations 
in CS rates.8 15 17 32–34 Positive correlations with CS rates 
have been shown for gross domestic product per capita, 
proportion of the population living in urban areas, 
number of doctors and for the presence of a skilled birth. 
An increased percentage of childbirth interventions in 
private hospitals compared with public hospitals has also 
been described.15 17 32
Few studies have focused on variations in childbirth 
interventions other than CS or rates of several childbirth 
interventions together. In 1990, Notzon described sharp 
differences in rates of CSs in 21 countries and rates of 
instrument-assisted births in 14 countries.9 In 1993, 
Stephenson et al described a 3-fold difference in CSs and 
a 10-fold difference in instrument-assisted vaginal births 
in 12 countries.35 The European Perinatal Health Report 
confirmed major variation in rates of interventions such 
as CSs, instrument-assisted births, induction of labour, 
episiotomy and births without childbirth interventions 
in 2004 and 2010 in Europe.8 For example, a secondary 
analysis of these data showed that national episiotomy 
rates in all vaginal births ranged from 4.9% in Denmark 
to 75.0% in Cyprus.36 Festin et al37 found significant vari-
ation in the practice of active management of the third 
stage of labour in 10 countries.37 Patterns of associations 
between childbirth interventions, such as CSs and the use 
of instruments, and epidurals and intrapartum oxytocin 
use, have been shown.5 8 38 39
In addition to the variation in childbirth interven-
tions, intercountry variations in maternal and perinatal 
outcomes also exist.8 40 For example, the proportion 
of women with obstetric anal sphincter injury (OASI) 
ranged from 0.1% in Poland and Romania and 0.3% in 
Slovenia to over 4% in Denmark and Iceland.36 While the 
maternal mortality rate in most countries in Europe has 
not declined significantly over the past decades, in some 
countries, including the USA, this rate has increased.8 41 
Perinatal mortality rates have declined in many countries 
worldwide and wide variations persist; however, these 
figures might be influenced by registration differences 
and under-reporting in some countries.8 42 43 Since differ-
ences in registration between countries occur, data must be 
interpreted with this in mind and figures of intervention 
rates must not be analysed without describing maternal 
and perinatal outcomes.
Because of the wide variations in rates of childbirth 
interventions and maternal and perinatal outcomes that 
exist between countries, it is important that childbirth 
interventions are analysed comprehensively, so that rates 
of several interventions can be compared and patterns 
can be better understood. This is the first study comparing 
rates of several interventions with the use of clear defini-
tions of the interventions and outcomes to facilitate mean-
ingful comparisons. This study aims to describe the range 
of variations in commonly used childbirth interventions 
in nulliparous and multiparous women in high-income 
countries around the world, and outcomes, by comparing 
these rates among multiple countries.
MEthods And AnAlysIs
research design and setting
This multinational cross-sectional study uses existing data 
from childbearing women in 2013. The year 2013 was 
chosen to ensure that required data were available for all 
participating countries, and were as recent as possible. 
Data will be analysed in the Netherlands, during the 
autumn of 2017 and analyses will continue throughout 
2018. High-income countries were selected on the basis of 
their representation in the COST Action IS1405 ‘BIRTH’ 
(European Cooperation in Science and Technology),44 
and whether the necessary data for this study were avail-
able. Low-income countries are not included because 
of the difficulties in comparing them with high-income 
countries due to differences in healthcare services and 
access to care.45 Countries that were not in the COST 
Action were also invited to reach more global coverage, 
and so the use of interventions among countries with 
diverse maternity care systems could be compared. Partic-
ipating countries are Belgium, Canada, Chile, Denmark, 
England, Germany, Iceland, Ireland, Italy, Malta, the 
Netherlands, Northern Ireland, Norway and the USA. 
The reporting of this study will adhere to the Strength-
ening the Reporting of Observational Studies in Epide-
miology guidelines.
Participants
Data from all women in participating countries, or from 
a representative sample of the population, who gave birth 
to a single child from 37 weeks gestation onwards in 
2013 are eligible for inclusion. For countries that cannot 
provide data from all women who gave birth in 2013, a 
representative sample of the population will be included. 
Which proportion of the total population it concerns, 
will be clearly described. Sample size calculation was 
not performed, because all available and eligible data 
from the participating countries for the year 2013 were 
included. Countries for which no data on parity, gesta-
tional age at birth and singleton or multiple gestation 
were available, were excluded.
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Patient involvement
Informed consent was not sought and women were not 
involved in the design of this study, because only anony-
mised national data or data from a representative sample 
of the population from 2013 will be used, which in 
most countries was routinely collected or collected after 
informed consent.
outcome measures
Primary outcomes
The following variables are defined as primary outcomes: 
induction of labour (none; cervical ripening; artificial 
rupture of membranes; oxytocin; other method; unspec-
ified), augmentation of labour, intrapartum use of 
oxytocin, artificial rupture of membranes, intrapartum 
antibiotics, epidural/spinal anaesthesia for labour (CS 
excluded), other pharmacological pain relief (none; 
systemic (non-)opioid analgesia; inhaled nitrous oxide; 
other; unspecified), episiotomy in vaginal births (none; 
mediolateral; midline; unspecified), spontaneous vaginal 
birth, instrument-assisted birth (International Classi-
fication of Diseases (ICD) code 081) (none; vacuum 
extraction; forceps delivery; unspecified), CS (ICD code 
082) (none; planned; emergency; unspecified), active 
management of third stage of labour and use of oxytocin 
within 2 hours postpartum.
Secondary outcomes
Secondary outcomes are perinatal mortality, Apgar score 
below 7 at 5 min, maternal mortality, postpartum haem-
orrhages ≥1000 mL (ICD code 072) and OASI (ICD code 
070.2 and 070.3).
Definitions
Clear operational definitions of the interventions and 
childbirth outcome measures will be used in order to 
allow valid international comparisons. Definitions of vari-
ables will vary among the countries. To ensure optimal 
uniformity, detailed instructions for the definitions of the 
variables will be given to the investigators.
Spontaneous onset of labour
Spontaneous onset of labour means spontaneous onset 
of regular uterine contractions that was not preceded 
by cervical ripening or the use of any other method of 
inducing uterine contractions.
Induction of labour
For induction of labour, more than one method can be 
used. Induction is defined as a technique to stimulate 
uterine contractions artificially prior to spontaneous 
contractions and includes administration of oxytocin to 
stimulate uterus contractions after spontaneous ruptured 
membranes in the absence of uterine contractions, or 
administration of oxytocin after cervical ripening and/
or artificial rupture of membranes.46 Cervical ripening 
is defined as an application of cervical ripening agents 
(such as prostaglandins) or mechanical interventions 
(such as insertion of catheters) and is also included in 
the definition of induction of labour.
Augmentation of labour
Augmentation of labour is the administration of oxytocin 
to stimulate uterus contractions after spontaneous onset 
of labour.47
Artificial rupture of membranes
Artificial rupture of membranes means breaking the 
amniotic fluid sac artificially, regardless of the moment 
(before or during labour) or indication (eg, for induc-
tion of labour).
Epidural anaesthesia
Epidural/spinal/neuroaxial anaesthesia refers to its use 
for pain management during labour contractions (spon-
taneous or induced). In case of a planned CS, epidural 
anaesthesia is considered not applicable and will be 
defined as no epidural anaesthesia.
Episiotomy in vaginal births
An episiotomy is the use of a deliberate incision of the 
perineum to accelerate vaginal birth.48 Episiotomy will be 
described for women with vaginal births only.
Caesarean section
Planned CS is defined as a CS that was planned before 
onset of labour and was performed electively before 
or after spontaneous onset of labour. Emergency CS is 
defined as a CS that was not planned prior to the onset 
of labour.
Active management of the third stage of labour and oxytocin in the 
postpartum period
Active management of the third stage of labour is defined 
as a combination of administration of an uterotonic agent 
after birth, early cord clamping and controlled cord 
traction. For use of oxytocin in the postpartum period, 
oxytocin can be administered intravenously or intramus-
cularly within 2 hours postpartum, including oxytocin 
use for induction or augmentation of labour which is 
continued after birth.
Mortality
Perinatal and maternal mortality are defined as mortality 
within 7 days postpartum.
Obstetric anal sphincter injury
OASI is a tear that extends to the external anal sphincter 
or when the rectal mucosa is torn.
Countries and data source characteristics in 2013
The following data will be collected to provide an overview 
of the characteristics of the countries represented in this 
study: total number of inhabitants, number of births in 
the country in 2013, proportion of births in the provided 
dataset, Gross National Income per capita in 2013 (as 
specified by the World Bank45), source of the data (civil 
registration; medical birth register or child health system; 
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hospital discharge system; perinatal survey; confidential 
enquiry; other routine surveys; linked data source) and 
the organisation responsible for providing the data.
Independent variables
Independent variables are parity (nulliparous; multip-
arous), maternal age at the time of giving birth (<20; 
20–24; 25–29; 30–34; 35–39; ≥40 years), maternal body 
mass index (BMI) (<18.5; 18.5–24.9; 25.0–29.9; 30.0–
34.9; 35.0–39.9; ≥40.0 kg/m2), gestational weight gain 
(mean and IQR, in grams), ethnic background, socio-
economic status (high; medium; low), gestational age at 
birth (37; 38; 39; 40; 41; ≥42 weeks), birth weight (<2500; 
2500–3499; 3500–4499; ≥4500 g), place of birth (hospital; 
birth centre; home; other) and care provider respon-
sible at onset of labour and at birth (midwife; obstetri-
cian/gynaecologist; nurse midwife; general practitioner; 
other). Categories for ethnic background will depend on 
national classifications and will therefore vary between 
countries. The definition of ethnicity that is used in each 
country will be used to describe ethnicity in the descrip-
tive analyses. When data from all countries are collected, 
an attempt will be made to provide a uniform defini-
tion (if possible) to enable adjustment for ethnicity. It 
may not be possible for most of the countries to collect 
data on whether a woman is a refugee or a migrant (as 
definitions of ‘migrant’ vary across the countries). The 
variable socioeconomic status will be categorised as high 
(75th percentile), medium (25th–75th percentile) and 
low (25th percentile) and the definition will also depend 
on national classifications. Some countries are not able 
to provide information on socioeconomic status and will 
therefore provide another variable that relates to socio-
economic status, such as education. How socioeconomic 
status is defined, will be clearly described for each country. 
An attempt will be made to provide a uniform definition 
(if possible) to enable adjustment for socioeconomic 
status. Place of birth will be categorised as in a hospital 
(a hospital where a CS can be performed), birth centre 
(a centre or hospital where a CS cannot be performed), 
home and other.
Analysis
The results will be analysed and presented by country and 
will be stratified by parity. The results will be reported 
in absolute numbers and percentages. Univariable anal-
yses will be performed to report on variations in rates of 
interventions and multivariable logistic regression anal-
yses will be conducted to investigate variations among 
countries adjusted for maternal age, maternal BMI, 
gestational weight gain, ethnic background, socioeco-
nomic status and infant birth weight. Because stratifica-
tion by parity will not be used for outcomes with only a 
few cases, for these outcomes adjustments for parity will 
be added. ORs and 99% CIs will be used to compare the 
probability of interventions and the risk for maternal and 
perinatal outcomes compared with the weighted mean 
rate of the complete dataset, to ensure that all countries 
contribute equally to the analyses. For the multivariable 
logistic regression analyses, outcome variables will be 
dichotomised and dummy variables will be created for 
potential confounders. To give a better understanding 
of the relationships between interventions, the results of 
interventions will be linked (such as emergency CS and 
instrument-assisted births) and illustrated in box plots 
with adjusted ORs and 99% CIs. Statistical analyses will 
be performed using STATA V.14 (StataCorp, College 
Station, Texas, USA).
Missing data
The amount and type of missing data will be reported 
for each variable by country. If a country’s dataset has 
no information about a specific variable or has data 
regarding a dependent variable with >10% missing, the 
country’s data will be excluded from the analysis for that 
specific variable. If a an independent variable included 
in the multivariable analyses is available, but there is >5% 
missing, data will be imputed using multiple imputation.
Ethical and data protection issues
Investigators will be asked to describe their national 
ethical standards and data protection laws. They will 
also be asked to report the proportion of cases for which 
data are missing in the dataset. Countries for which no 
anonymised crude data at the level of individual women 
can be provided, will participate with aggregated data 
and these data will be used in the descriptive analyses. 
Finally, investigators will be asked to provide information 
on the standard quality procedures of the data source 
and the provided dataset, how missing data are dealt with 
and contradictions, and how checks are done to ensure 
that all eligible births are recorded. If the conditions for 
participation of the country are met, a data access agree-
ment will be signed between the investigator’s institution 
and the VU University Medical Center.
EthICs And dIssEMInAtIon
The Medical Ethics Review Committee of VU Univer-
sity Medical Center Amsterdam confirmed that offi-
cial approval of this study was not required, because 
it concerns a secondary analysis of existing data (refer-
ence 2016.317). This multinational cross-sectional study 
with data from high-income countries will describe vari-
ations in childbirth interventions and maternal and 
perinatal outcomes. A comparison of intervention rates 
and rates of childbirth outcomes between countries will 
identify opportunities to improve maternal and peri-
natal outcomes. Results will be disseminated at national 
and international conferences and published in peer-re-
viewed journals.
dIsCussIon
For some interventions, there is lack of consensus and 
ongoing debate about indications for their use and 
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whether an intervention is necessary, for example, 
planned CS for breech presentations, or after a previous 
CS,8 or the use of episiotomy for prevention of major peri-
neal tears in nulliparous and multiparous women.49 It is 
important to avoid unnecessary interventions in child-
bearing women and at the same time ensure that those 
interventions that are necessary take place.
This study only aims to describe variation in inter-
vention rates, related to a number of maternal and 
birth characteristics. The design of this study is inap-
propriate for making causal associations. Therefore, 
the results need to be interpreted with caution. Indica-
tions for the use of childbirth interventions are rarely 
reported clearly in national data. Although multivari-
able analyses are conducted to adjust for characteris-
tics, the indications for the use of interventions cannot 
be included in this study. Also other potential maternal 
confounders such as pre-existing medical condition 
and previous history cannot be included. This limits 
interpretation of the results, and reveals at the same 
time that auditing indications of childbirth inter-
ventions is important to ensure better comparisons 
between countries in future studies.
A major strength of this study is the use of crude 
data at the level of individual women and the use of 
strict definitions. This will allow us to conduct multi-
variable analyses and make valid comparisons between 
countries. As described before, the literature shows 
patterns of associations between commonly used child-
birth interventions. Our data will permit exploration 
of these associations between interventions, which will 
give a better understanding of the patterns of interven-
tion use and the impact of variations on mother and 
child.
Studying variations in a large number of interven-
tions across countries will inform the debate about 
optimal rates and the results will contribute to the 
improvement of the quality of care. In subsequent 
studies, factors influencing major variations in inter-
vention rates can be examined and addressed.
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